Ink4a/Arf expression is a biomarker of aging

Journal of Clinical Investigation

Volumn 114, Issue 9, 2004, Pages 1299-1307

  Krishnamurthy, Janakiraman ^a   Torrice, Chad ^a   Ramsey, Matthew R ^a   Kovalev, Grigoriy I ^a   Al Regaiey, Khalid ^b   Su, Lishan ^a   Sharpless, Norman E ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARF PROTEIN; BIOLOGICAL MARKER; PROTEIN P16INK4A; TRANSCRIPTION FACTOR ER81; TUMOR SUPPRESSOR PROTEIN; ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR 1; BETA GALACTOSIDASE;

AGING; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALORIC RESTRICTION; CELL AGING; EPITHELIUM CELL; FEMALE; GENE LOCUS; HEART; HUMAN; HUMAN TISSUE; IN VIVO STUDY; KIDNEY; MALE; MOUSE; NONHUMAN; OVARY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL; ANIMAL; BIOLOGICAL MODEL; BIOSYNTHESIS; CELL CYCLE; DISEASE MODEL; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; POLYMERASE CHAIN REACTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME; TISSUE DISTRIBUTION;

ADP-RIBOSYLATION FACTOR 1; AGING; ANIMALS; BETA-GALACTOSIDASE; BIOLOGICAL MARKERS; CALORIC RESTRICTION; CELL CYCLE; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MODELS, BIOLOGICAL; POLYMERASE CHAIN REACTION; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 84900969225     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI22475     Document Type: Article

References (63)

1. Guarence, L., and Kenyon, C. 2000. Genetic pathways that regulate ageing in model organisms. Nature. 408:255-262.
2. Park, I.K., Morrison, S.J., and Clarke, M.F. 2004. Bmi1, stem cells, and senescence regulation. J. Clin. Invest. 113:175-179. doi:10.1172/JCI200420800.
3. Campisi, J. 2003. Cancer and ageing: rival demons? Nat. Rev. Cancer. 3:339-349.
4. Sharpless, N.E., and DePinho, R.A. 2002. p53: good cop/bad cop. Cell. 110:9-12.
5. Artandi, S.E., et al. 2000. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature. 406:641-645.
6. Tyner, S.D., et al. 2002. p53 mutant mice that display early ageing-associated phenotypes. Nature. 415:45-53.
7. Halvorsen, T.L., Beattie, G.M., Lopez, A.D., Hayek, A., and Levine, F. 2000. Accelerated telomere shortening and senescence in human pancreatic islet cells stimulated to divide in vitro. J. Endocrinol. 166:103-109.
8. Alcorta, D.A., et al. 1996. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc. Natl. Acad. Sci. U. S. A. 93:13742-13747.
9. Kamijo, T., et al. 1997. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell. 91:649-659.
10. Kiyono, T., et al. 1998. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature. 396:84-88.
11. Rheinwald, J.G., et al. 2002. A two-stage, p16(INK4A)- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status. Mol. Cell. Biol. 22:5157-5172.
12. Randle, D.H., Zindy, F., Sherr, C.J., and Roussel, M.F. 2001. Differential effects of p19(Arf) and p16(Ink4a) loss on senescence of murine bone marrow-derived preB cells and macrophages. Proc. Natl. Acad. Sci. U. S. A. 98:9654-9659.
13. Chkhotua, A.B., et al. 2003. Increased expression of p16 and p27 cyclin-dependent kinase inhibitor genes in aging human kidney and chronic allograft nephropathy. Am. J. Kidney Dis. 41:1303-1313.
14. Kajstura, J., et al. 2000. Telomere shortening is an in vivo marker of myocyte replication and aging. Am. J. Pathol. 156:813-819.
15. Melk, A., et al. 2003. Cell senescence in rat kidneys in vivo increases with growth and age despite lack of telomere shortening. Kidney Int. 63:2134-2143.
16. Melk, A., et al. 2004. Expression of p16INK4a and other cell cycle regulator and senescence associated genes in aging human kidney. Kidney Int. 65:510-520.
17. Nielsen, G.P., et al. 1999. Immunohistochemical survey of p16INK4A expression in normal human adult and infant tissues. Lab Invest. 79:1137-1143.
18. Zindy, F., Quelle, D.E., Roussel, M.F., and Sherr, C.J. 1997. Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging. Oncogene. 15:203-211.
19. Kanavaros, P., et al. 2001. Immunohistochemical expression of p53, p21/waf1, rb, p16, cyclin D1, p27, Ki67, cyclin A, cyclin B1, bcl2, bax and bak proteins and apoptotic index in normal thymus. Histol. Histopathol. 16:1005-1012.
20. Lessard, J., and Sauvageau, G. 2003. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature. 423:255-260.
21. Park, I.K., et al. 2003. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature. 423:302-305.
22. Molofsky, A.V., et al. 2003. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature. 425:962-967.
23. Lewis, J.L., et al. 2001. The influence of INK4 proteins on growth and self-renewal kinetics of hematopoietic progenitor cells. Blood. 97:2604-2610.
24. Meng, A., Wang, Y., Van Zant, G., and Zhou, D. 2003. Ionizing radiation and busulfan induce premature senescence in murine bone marrow hematopoietic cells. Cancer Res. 63:5414-5419.
25. Sherr, C.J. 2000. The Pezcoller lecture: cancer cell cycles revisited. Cancer Res. 60:3689-3695.
26. Phelps, D.E., et al. 1998. Coupled transcriptional and translational control of cyclin-dependent kinase inhibitor p18INK4c expression during myogenesis. Mol. Cell. Biol. 18:2334-2343.
27. Pagano, M., et al. 1995. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science. 269:682-685.
28. Sherr, C.J., and DePinho, R.A. 2000. Cellular senescence: mitotic clock or culture shock? Cell. 102:407-410.
29. Ha, T.U., et al. 2000. Mullerian inhibiting substance inhibits ovarian cell growth through an Rb-independent mechanism. J. Biol. Chem. 275:37101-37109.
30. Ruas, M., and Peters, G. 1998. The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim. Biophys. Acta. 1378:F115-F177.
31. Uchida, N., and Weissman, I.L. 1992. Searching for hematopoietic stem cells: evidence that Thy-1.1lo Lin- Sca-1+ cells are the only stem cells in C57BL/Ka-Thy-1.1 bone marrow. J. Exp. Med. 175:175-184.
32. Masoro, E.J. 2003. Subfield history: caloric restriction, slowing aging, and extending life. Sci. Aging Knowledge Environ. 2003:RE2.
33. Turturro, A., et al. 1999. Growth curves and survival characteristics of the animals used in the Biomarkers of Aging Program. J. Gerontol. A Biol. Sci. Med. Sci. 54:B492-B501.
34. Yu, B.P., Masoro, E.J., Murata, I., Bertrand, H.A., and Lynd, F.T. 1982. Life span study of SPF Fischer 344 male rats fed ad libitum or restricted diets: longevity, growth, lean body mass and disease. J. Gerontol. 37:130-141.
35. Miller, R.A. 2001. Genetics of increased longevity and retarded aging in mice. In Handbook of the biology of aging E.J. Masoro and S.N. Austad, editors. Academic Press Inc. San Diego, California, USA. 369-395.
36. Bartke, A., et al. 2001. Extending the lifespan of long-lived mice [letter]. Nature. 414:412.
37. Coschigano, K.T., Clemmons, D., Bellush, L.L., and Kopchick, J.J. 2000. Assessment of growth parameters and life span of GHR/BP gene-disrupted mice. Endocrinology. 141:2608-2613.
38. Miller, R.A., et al. 2002. Gene expression patterns in calorically restricted mice: partial overlap with long-lived mutant mice. Mol. Endocrinol. 16:2657-2666.
39. Dimri, G.P., et al. 1995. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. U. S. A. 92:9363-9367.
40. Ohtani, N., et al. 2001. Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence. Nature. 409:1067-1070.
41. Huot, T.J., et al. 2002. Biallelic mutations in p16(INK4a) confer resistance to Ras- and Ets-induced senescence in human diploid fibroblasts. Mol. Cell. Biol. 22:8135-8143.
42. Alani, R.M., Young, A.Z., and Shifflett, C.B. 2001. Id1 regulation of cellular senescence through transcriptional repression of p16/Ink4a. Proc. Natl. Acad. Sci. U. S. A. 98:7812-7816.
43. Jacobs, J.J., Kieboom, K., Marino, S., DePinho, R.A., and van Lohuixen, M. 1999. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature. 397:164-168.
44. Hara, E., et al. 1996. Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol. Cell. Biol. 16:859-867.
45. Jacobs, J.J., et al. 2000. Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers. Nat. Genet. 26:291-299.
46. Palmero, I., Pantoja, C., and Serrano, M. 1998. p19ARF links the tumour suppressor p53 to Ras. Nature. 395:125-126.
47. Serrano, M., et al. 1996. Role of the INK4a locus in tumor suppression and cell mortality. Cell. 85:27-37.
48. Sun, L.Q., et al. 2004. Growth retardation and premature aging phenotypes in mice with disruption of the SNF2-like gene, PASG. Genes Dev. 8:1035-1046.
49. Sharpless, N.B., et al. 2001. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature. 413:86-91.
50. Engwerda, C.R., Handwerger, B.S., and Fox, B.S. 1994. Aged T cells are hyporesponsive to costimulation mediated by CD28. J. Immunol. 152:3740-3747.
51. Yoshimi, N., et al. 1996. Telomerase activity of normal tissues and neoplasms in rat colon carcinogenesis induced by methylazoxymethanol acetate and its difference from that of human colonic tissues. Mol. Carcinog. 16:1-5.
52. Prowse, K.R., and Greider, C.W. 1995. Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc. Natl. Acad. Sci. U. S. A. 92:4818-4822.
53. Wasylyk, C., Bradford, A.P., Gutierrez-Hartmann, A., and Wasylyk, B. 1997. Conserved mechanisms of Ras regulation of evolutionary related transcription factors, Ets1 and Pointed P2. Oncogene. 14:899-913.
54. Paumelle, R., et al. 2002. Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway. Oncogene. 21:2309-2319.
55. Tanaka, K., Oda, N., Iwasaka, C., Abe, M., and Sato, Y. 1998. Induction of Ets-1 in endothelial cells during reendothelialization after denuding injury. J. Cell. Physiol. 176:235-244.
56. Bulavin, D.V., et al. 2004. Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway. Nat. Genet. 36:343-350.
57. Leung, C., et al. 2004. Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas. Nature. 428:337-341.
58. Gil, J., Bernard, D., Martinez, D., and Beach, D. 2004. Polycomb CBX7 has a unifying role in cellular lifespan. Nat. Cell Biol. 6:67-72.
59. Kranc, K.R., et al. 2003. Transcriptional coactivator Cited2 induces Bmi1 and Mel18 and controls fibroblast proliferation via Ink4a/ARF. Mol. Cell. Biol. 23:7658-7666.
60. Brunet, A., et al. 2004. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science. 303:2011-2015.
61. Cohen, H.Y., et al. 2004. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science. 305:390-392.
62. Mikaelian, I., et al. 2004. Antibodies that label paraffin-embedded mouse tissues: a collaborative endeavor. Toxicol. Pathol. 32:181-191.
63. Chimenti, C., et al. 2003. Senescence and death of primitive cells and myocytes lead to premature cardiac aging and heart failure. Circ. Res. 93:604-613.